{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:50:54Z","timestamp":1790358654382,"version":"4.1.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1097\/mlr.0b013e31820192cd","type":"journal-article","created":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T04:42:55Z","timestamp":1294720975000},"page":"267-272","source":"Crossref","is-referenced-by-count":51,"title":["Willingness to Pay per Quality-Adjusted Life Year: Is One Threshold Enough for Decision-Making?"],"prefix":"10.1097","volume":"49","author":[{"given":"Fei-Li","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiu-Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Chuen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210211","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1524-4733.2008.00360.x","article-title":"Emerging health economics and outcomes research in the Asia-Pacific region.","volume":"11","author":"Liu","year":"2008","journal-title":"Value Health"},{"key":"R2-7-20210211","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1111\/j.1524-4733.2008.00363.x","article-title":"Cost-utility analysis of intensive blood glucose control with metformin versus usual care in overweight type 2 diabetes mellitus patients in Beijing, P.R. China.","volume":"11","author":"Xie","year":"2008","journal-title":"Value Health"},{"key":"R4-7-20210211","article-title":"Macroeconomics and health: investing in health for economic development. Report of the WHO Commission on Macroeconomics and Health.","year":"2001"},{"key":"R5-7-20210211","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1524-4733.2004.75003.x","article-title":"Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?","volume":"7","author":"Eichler","year":"2004","journal-title":"Value Health"},{"key":"R6-7-20210211","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hec.1481","article-title":"International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?","volume":"19","author":"Shiroiwa","year":"2010","journal-title":"Health Econ"},{"key":"R7-7-20210211","article-title":"National Institute for Health and Clinical Excellence.","year":"2007"},{"key":"R8-7-20210211","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/0272989X05283136","article-title":"Does willingness to pay per quality-adjusted life year bring us closer to a useful decision rule for cost-effectiveness analysis?","volume":"25","author":"Polsky","year":"2005","journal-title":"Med Decis Making"},{"key":"R9-7-20210211","article-title":"Using Surveys to Value Public Goods: The Contingent Valuation Method.","author":"Mitchell","year":"1989"},{"key":"R10-7-20210211","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/14737167.8.6.575","article-title":"Willingness to pay for a QALY: past, present and future.","volume":"8","author":"Mason","year":"2008","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"R11-7-20210211","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2165\/00019053-200523050-00002","article-title":"Willingness to pay for a QALY: theoretical and methodological issues.","volume":"23","author":"Gyrd-Hansen","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"R12-7-20210211","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1524-4733.2010.00728.x","article-title":"Validation and comparison of EuroQol and Short Form 6D in chronic prostatitis patients.","volume":"13","author":"Zhao","year":"2010","journal-title":"Value Health"},{"key":"R13-7-20210211","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1111\/j.1524-4733.2008.00371.x","article-title":"A study on indirect and intangible costs for patients with knee osteoarthritis in Singapore.","volume":"11","author":"Xie","year":"2008","journal-title":"Value Health"},{"key":"R15-7-20210211","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/0272989X05282638","article-title":"Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis.","volume":"25","author":"Byrne","year":"2005","journal-title":"Med Decis Making"},{"key":"R16-7-20210211","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/0272989X05282640","article-title":"Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.","volume":"25","author":"King","year":"2005","journal-title":"Med Decis Making"},{"key":"R18-7-20210211","article-title":"Guide to the methods of technology appraisal.","year":"2008"},{"key":"R19-7-20210211","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1037\/0278-6133.1.1.61","article-title":"Health-related quality of life measurement for evaluation research and policy analysis.","volume":"1","author":"Kaplan","year":"1982","journal-title":"Health Psychol"},{"key":"R20-7-20210211","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1464-410X.2004.05002.x","article-title":"An epidemiological study of patients with chronic prostatitis.","volume":"94","author":"Liang","year":"2004","journal-title":"BJU Int"},{"key":"R21-7-20210211","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0195-9255(03)00138-0","article-title":"The contingent valuation method: a review.","volume":"24","author":"Venkatachalam","year":"2004","journal-title":"Environ Impact Assess Rev"}],"container-title":["Medical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MLR.0b013e31820192cd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:48:08Z","timestamp":1786042088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005650-201103000-00007"}},"subtitle":["Results From a Study in Patients With Chronic Prostatitis"],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mlr.0b013e31820192cd","relation":{},"ISSN":["0025-7079"],"issn-type":[{"value":"0025-7079","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}